We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Charmaine
Childs
c.childs@shu.ac.uk
Prof
Charmaine
Childs
c.childs@shu.ac.uk
Diseases of arteries, arterioles and capillaries
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Peripheral artery disease (PAD) affects > 200 million people worldwide. As the second most common manifestation of atherosclerosis, PAD predominately affects lower-limb/s.
Our study objective is method development of a clinical protocol and database to underpin development of a new, non-invasive imaging modality; one which will provide objective pre- and post-operative leg and foot tissue haemodynamics. This development will be undertaken by involving the public and patients in the design and development of the method and eventual clinical protocol. The goal is to provide skin perfusion surveillance technology for rational surgical decision making, vascular assessment for people with PAD (with and without diabetes), improved surgical outcomes and NHS cost-burden reduction. Ultimately, the technique could offer population screening for PAD across the spectrum, where disease is ‘silent’ in over 60% of people aged 50 years or more.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Imaging;Surgery;Active Monitoring;
You can take part if:
You may not be able to take part if:
1. Patients who, at this feasibility stage, are able to understand written and spoken English. (In this feasibility study, funding is not available for transcriptions or interpreters). 2. Patients who lack capacity
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST and funded by Medical Research Council (MRC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 60367
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
